A Randomized, Double-blind, Placebo Controlled, Withdrawal Study of Flare Prevention of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2009
This article has no abstract
Epistemonikos ID: a7e9932c493ee4a2b0ef3580766e04b1cd390176
First added on: Apr 16, 2025